Pioglitazone Tablets IP

Oct 28, 2022

Introduction

Pioglitazone, a potent oral anti-diabetic medication, is used in the treatment of type 2 diabetes mellitus. It belongs to a class of drugs known as thiazolidinediones, which work by improving the body’s sensitivity to insulin. PIOSTERIS 30, containing Pioglitazone (30mg), is prescribed to patients who need help in controlling their blood sugar levels. Diabetes is a chronic condition that requires careful management, and medications like PIOSTERIS 30 are part of an overall treatment plan that may include lifestyle changes, exercise, and dietary adjustments. By promoting better blood glucose control, this medication helps prevent or delay complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.

Understanding Pioglitazone

Pioglitazone is a member of the thiazolidinedione class of anti-diabetic drugs. It works primarily by targeting insulin resistance, a core feature of type 2 diabetes. Insulin resistance occurs when the body's cells do not respond properly to insulin, leading to high levels of glucose in the bloodstream. By enhancing the body’s response to insulin, Pioglitazone helps reduce blood glucose levels, thereby providing better control over the condition.

Pioglitazone works through several mechanisms:

  • Improving insulin sensitivity in muscle, liver, and fat tissue.
  • Reducing hepatic glucose production, which helps lower blood sugar levels.
  • Promoting glucose uptake by cells, enhancing the body’s ability to utilize available glucose efficiently.

PIOSTERIS 30 is specifically formulated with Pioglitazone (30mg) to provide an effective dose for managing blood glucose levels in patients with type 2 diabetes.

Uses of PIOSTERIS 30

PIOSTERIS 30 is primarily prescribed for the management of type 2 diabetes mellitus, especially in individuals who are not adequately controlled by diet and exercise alone. Type 2 diabetes is characterized by the body’s inability to use insulin effectively, and PIOSTERIS 30 helps address this issue by enhancing insulin sensitivity.

Some of the key uses of PIOSTERIS 30 include:

  1. Managing Blood Sugar Levels: By improving insulin sensitivity, PIOSTERIS 30 helps regulate blood sugar levels in patients with type 2 diabetes. This is crucial in preventing both short-term and long-term complications of the disease.

  2. Preventing Complications: Chronic high blood glucose levels can lead to severe complications such as heart disease, kidney failure, nerve damage, and vision problems. Regular use of PIOSTERIS 30, along with other diabetes management strategies, can help reduce the risk of these complications.

  3. Adjunct to Diet and Exercise: PIOSTERIS 30 is often used in combination with a healthy diet and regular physical activity to achieve optimal glucose control. It is not meant to replace a healthy lifestyle but rather to supplement it in those who are unable to maintain glucose control through lifestyle changes alone.

  4. As Part of Combination Therapy: In some cases, PIOSTERIS 30 may be prescribed in combination with other oral anti-diabetic medications like metformin, sulfonylureas, or insulin to achieve better glycemic control.

How Pioglitazone Works

Pioglitazone, the active ingredient in PIOSTERIS 30, acts on insulin resistance by interacting with peroxisome proliferator-activated receptors (PPARs) in the body. These receptors are found in various tissues, including fat, muscle, and the liver, and play a significant role in regulating glucose and fat metabolism.

Here is how Pioglitazone works in the body:

  1. Increases Insulin Sensitivity: Pioglitazone binds to the PPAR-gamma receptor in the body’s fat, liver, and muscle cells. This binding enhances the cells' ability to respond to insulin, leading to better glucose uptake and utilization. As a result, the body requires less insulin to process glucose effectively.

  2. Reduces Hepatic Glucose Production: Pioglitazone also decreases the amount of glucose produced by the liver. This is important because, in type 2 diabetes, the liver often releases too much glucose into the bloodstream, exacerbating hyperglycemia. By reducing this overproduction of glucose, Pioglitazone helps maintain stable blood sugar levels.

  3. Improves Lipid Profiles: In addition to its effects on glucose, Pioglitazone may have a positive effect on lipid metabolism. It can lower levels of triglycerides and increase high-density lipoprotein (HDL), or “good” cholesterol, contributing to better cardiovascular health.

  4. Reduces Inflammation: Pioglitazone also has anti-inflammatory properties. Chronic inflammation is thought to play a role in the development and progression of insulin resistance, so Pioglitazone’s ability to reduce inflammation may further improve insulin sensitivity.

Dosage and Administration

The recommended starting dose of PIOSTERIS 30 is usually 15mg to 30mg once daily, depending on the individual patient's needs and response to treatment. The dosage may be adjusted based on the patient's blood sugar levels, tolerance, and other factors.

In some cases, the dosage can be increased up to 45mg per day, but this should only be done under a healthcare provider’s supervision. Patients are advised to take PIOSTERIS 30 with or without food, as food does not significantly affect its absorption.

It is essential for patients to follow the prescribed dosage regimen and never adjust the dose without consulting a doctor. Overuse or underuse of the medication can lead to poor blood sugar control, which may cause complications.

Side Effects of PIOSTERIS 30

Like any medication, PIOSTERIS 30 may cause side effects. The severity and occurrence of side effects vary from person to person. While many individuals tolerate Pioglitazone well, others may experience unwanted effects. Some of the most common side effects include:

  1. Weight Gain: One of the more common side effects of Pioglitazone is weight gain. This is often due to fluid retention, as Pioglitazone can increase fat storage in the body. However, the weight gain is generally modest and can be managed by regular monitoring and a balanced diet.

  2. Edema (Fluid Retention): Some patients may experience swelling in the legs, ankles, or feet. This is also due to fluid retention and can worsen in patients with heart problems.

  3. Hypoglycemia (Low Blood Sugar): When taken in combination with other anti-diabetic drugs, particularly insulin or sulfonylureas, Pioglitazone may increase the risk of hypoglycemia. Symptoms of hypoglycemia include shaking, sweating, confusion, and dizziness.

  4. Liver Issues: Rarely, Pioglitazone can affect liver function. Patients are typically monitored for liver enzyme levels during treatment, and any abnormal results may lead to discontinuation of the drug.

  5. Bone Fractures: Long-term use of Pioglitazone has been linked to an increased risk of bone fractures, particularly in women. This is thought to be due to the medication’s effect on bone metabolism.

  6. Bladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer, particularly in individuals who have used it for an extended period. Patients with a history of bladder cancer or other urinary tract issues should discuss alternative treatments with their healthcare provider.

  7. Heart Failure: In rare cases, Pioglitazone can cause or worsen heart failure, especially in individuals with pre-existing heart conditions. It is essential for patients to inform their doctors about any heart problems before starting Pioglitazone therapy.

Precautions and Warnings

Before starting PIOSTERIS 30, patients should inform their healthcare provider about their medical history, especially concerning the following:

  • Heart Conditions: Pioglitazone should be used cautiously in patients with a history of heart failure or other heart conditions, as it may worsen fluid retention and exacerbate heart failure symptoms.

  • Liver Disease: Pioglitazone is processed by the liver, so patients with liver diseases should be closely monitored while on this medication.

  • Kidney Function: While Pioglitazone is not primarily excreted by the kidneys, its use should be cautious in individuals with impaired kidney function.

  • Pregnancy and Breastfeeding: Pioglitazone should be used during pregnancy only if the potential benefits justify the potential risks to the fetus. It is also unknown whether Pioglitazone passes into breast milk, so it should be used with caution in breastfeeding mothers.

Conclusion

PIOSTERIS 30 (Pioglitazone 30mg) plays a significant role in the management of type 2 diabetes by improving insulin sensitivity and helping control blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which includes a balanced diet, regular physical activity, and other lifestyle modifications.

Patients taking PIOSTERIS 30 should work closely with their healthcare providers to monitor their progress, manage side effects, and make any necessary adjustments to their treatment regimen. Although Pioglitazone is generally well tolerated, it is essential for patients to be aware of potential side effects and take appropriate precautions, especially those with heart, liver, or kidney conditions.

As with any medication, consistent use and monitoring are key to maximizing the benefits of PIOSTERIS 30 while minimizing risks. With proper care and attention, patients can better manage their diabetes and reduce the risk of complications associated with this chronic condition.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

 

SHARE WITH